Effectiveness of Applying Green Heart, a Smartphone-Based Self-management Intervention to Control Smoking: A Randomized Clinical Trial.

IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Archives of Iranian Medicine Pub Date : 2024-05-01 DOI:10.34172/aim.2024.37
Mojgan Ghavami, Alireza Abdshah, Ayat Ahmadi, Diba Akbarzadeh, Ali Mofidi, Mahnaz Ashoorkhani, Saeed Sadeghian
{"title":"Effectiveness of Applying Green Heart, a Smartphone-Based Self-management Intervention to Control Smoking: A Randomized Clinical Trial.","authors":"Mojgan Ghavami, Alireza Abdshah, Ayat Ahmadi, Diba Akbarzadeh, Ali Mofidi, Mahnaz Ashoorkhani, Saeed Sadeghian","doi":"10.34172/aim.2024.37","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases (CVDs) pose a significant global health concern and are the most common cause of death and disability, necessitating preventive interventions targeting modifiable risk factors. Recently, mobile-health technology has been developed to improve the delivery of cardiovascular prevention by risk factor modification. The \"Green Heart\" mobile application (app) was designed to aid in risk factor control among coronary artery disease (CAD) patients.</p><p><strong>Methods: </strong>This parallel-group, single-blinded randomized controlled trial enrolled 1590 CAD patients, including 668 current smokers, randomly assigned to control (paper-based education) and intervention (application-based) groups. The app encompassed three modules targeting smoking cessation, dyslipidemia control, and blood pressure management. This study evaluated the impact of the smoking cessation module on behavioral change among current smokers. Green Heart assesses nicotine dependence, offering personalized quit plans, educational content, motivational messages, and automated progress tracking. The odds of smoking behavior changes during the 24-week follow-up underwent assessment.</p><p><strong>Results: </strong>The intention-to-treat analysis highlighted significantly elevated rates of smoking cessation and reductions in the intervention group versus the control group. Adherence to the app (per-treatment analysis) also demonstrated significantly more favorable smoking behavior changes among the application users. Logistic regression emphasized higher odds of quitting and reduction in smoking in the application group, showing an odds ratio of 2.14 (95% CI: 1.16-3.97) compared to those not using the app (<i>P</i>=0.015).</p><p><strong>Conclusion: </strong>Our results confirmed that complete adherence to the app for at least 24 weeks was linked to alterations in cigarette smoking behavior among CAD patients. <b>Trial Registration Number:</b> IRCT20221016056204N1.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"27 5","pages":"255-264"},"PeriodicalIF":1.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11097320/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Iranian Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.34172/aim.2024.37","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cardiovascular diseases (CVDs) pose a significant global health concern and are the most common cause of death and disability, necessitating preventive interventions targeting modifiable risk factors. Recently, mobile-health technology has been developed to improve the delivery of cardiovascular prevention by risk factor modification. The "Green Heart" mobile application (app) was designed to aid in risk factor control among coronary artery disease (CAD) patients.

Methods: This parallel-group, single-blinded randomized controlled trial enrolled 1590 CAD patients, including 668 current smokers, randomly assigned to control (paper-based education) and intervention (application-based) groups. The app encompassed three modules targeting smoking cessation, dyslipidemia control, and blood pressure management. This study evaluated the impact of the smoking cessation module on behavioral change among current smokers. Green Heart assesses nicotine dependence, offering personalized quit plans, educational content, motivational messages, and automated progress tracking. The odds of smoking behavior changes during the 24-week follow-up underwent assessment.

Results: The intention-to-treat analysis highlighted significantly elevated rates of smoking cessation and reductions in the intervention group versus the control group. Adherence to the app (per-treatment analysis) also demonstrated significantly more favorable smoking behavior changes among the application users. Logistic regression emphasized higher odds of quitting and reduction in smoking in the application group, showing an odds ratio of 2.14 (95% CI: 1.16-3.97) compared to those not using the app (P=0.015).

Conclusion: Our results confirmed that complete adherence to the app for at least 24 weeks was linked to alterations in cigarette smoking behavior among CAD patients. Trial Registration Number: IRCT20221016056204N1.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
应用 "绿色心脏"--基于智能手机的自我管理控烟干预的有效性:随机临床试验。
背景:心血管疾病(CVDs)是全球重大健康问题,也是导致死亡和残疾的最常见原因,因此有必要针对可改变的风险因素采取预防干预措施。最近,人们开发了移动医疗技术,通过改变风险因素来改善心血管疾病的预防工作。绿色心脏 "移动应用程序旨在帮助冠状动脉疾病(CAD)患者控制危险因素:这项平行分组、单盲随机对照试验共招募了 1590 名冠心病患者,其中包括 668 名当前吸烟者,他们被随机分配到对照组(纸质教育)和干预组(基于应用程序)。应用程序包括戒烟、血脂异常控制和血压管理三个模块。这项研究评估了戒烟模块对当前吸烟者行为改变的影响。绿心 "评估尼古丁依赖性,提供个性化戒烟计划、教育内容、激励信息和自动进度跟踪。对 24 周随访期间吸烟行为改变的几率进行了评估:结果:意向治疗分析显示,干预组的戒烟率和减烟率明显高于对照组。对应用程序的依从性(每次治疗分析)也表明,应用程序用户的吸烟行为变化明显更有利。逻辑回归结果表明,与未使用应用程序的人相比,应用程序组的戒烟和减烟几率更高,几率比为 2.14(95% CI:1.16-3.97)(P=0.015):我们的研究结果证实,完全坚持使用该应用程序至少 24 周与 CAD 患者吸烟行为的改变有关。试验注册号:IRCT20221016056204N1。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Archives of Iranian Medicine
Archives of Iranian Medicine 医学-医学:内科
CiteScore
4.20
自引率
0.00%
发文量
67
审稿时长
3-8 weeks
期刊介绍: Aim and Scope: The Archives of Iranian Medicine (AIM) is a monthly peer-reviewed multidisciplinary medical publication. The journal welcomes contributions particularly relevant to the Middle-East region and publishes biomedical experiences and clinical investigations on prevalent diseases in the region as well as analyses of factors that may modulate the incidence, course, and management of diseases and pertinent medical problems. Manuscripts with didactic orientation and subjects exclusively of local interest will not be considered for publication.The 2016 Impact Factor of "Archives of Iranian Medicine" is 1.20.
期刊最新文献
A Rare Anatomical Variation: Intrathoracic Liver Caudate Lobe: A Case Report. Clinicopathologic Effects of Xenogeneic GvHD Induced by Adoptively Transferred Human-Derived T Cells in Severely Immunodeficient Mice. Consequences of Infectious Disease Outbreaks in Ardabil (1925-1941): A Historical Analysis. First Case of Macrocephaly, Dysmorphic Facies, and Psychomotor Retardation Harboring Co-inherited Variants in HERC1 and PMP22 Genes from Iran: Two Novel Variants. Incidence and Risk Factors of Retinopathy of Prematurity in Southeastern Iran: A Retrospective Cohort Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1